Association of serum VEGF with clinical response to anti-TNFα therapy for Crohn's disease. Issue 2 (December 2015)

• Record Type: Journal Article
• Authors: Eder, Piotr; Korybalska, Katarzyna; Lykowska-Szuber, Liliana; Krela-Kazmierczak, Iwona; Stawczyk-Eder, Kamila; Klimczak, Katarzyna; Szymczak, Aleksandra; Linke, Krzysztof; Witowski, Janusz
• Is Part Of: Cytokine. Volume 76:Issue 2(2015)
• Page Start: 288
• Page End: 293
• Publication Date: 2015-12
• Subjects: Cytokines -- Periodicals; 571.844
• DOI: 10.1016/j.cyto.2015.09.018
• Languages: English
• ISSNs: 1043-4666

Abstract

<abstract xml:lang="en" abstract-type="author-highlights" id="ab005"> <title id="st005">Highlights</title> <sec> <p id="sp0005"> <list id="l0005"> <list-item id="o0005"> <label></label> <p id="p0005">Angiogenesis is one of the driving forces of inflammation in Crohn's disease.</p> </list-item> <list-item id="o0010"> <label></label> <p id="p0010">Factors predicting the efficacy of anti-TNFα antibodies are poorly defined.</p> </list-item> <list-item id="o0015"> <label></label> <p id="p0015">High baseline VEGF levels are associated with better therapeutic outcomes.</p> </list-item> <list-item id="o0020"> <label></label> <p id="p0020">Low baseline VEGF levels predict lower efficacy of anti-TNFα antibodies.</p> </list-item> </list> </p> </sec> </abstract>